triamterene has been researched along with Chronic Primary Open Angle Glaucoma in 1 studies
Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mills, KB | 1 |
| Gilbert, DJ | 1 |
| Ridgway, AE | 1 |
1 other study available for triamterene and Chronic Primary Open Angle Glaucoma
| Article | Year |
|---|---|
The effect of topical 0.5% triamterene suspension on the intraocular pressure of open angle glaucoma patients. A single dose study.
Topics: Administration, Topical; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Suspensions; Triamteren | 1984 |